Patents by Inventor Hongyue Zhang

Hongyue Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11553713
    Abstract: Disclosed are compositions and methods of pest control. The composition contains one or more active agents such as a polyalcohol, carbohydrate, nucleobase or nucleotide compound or derivative and one or more inactive ingredients which function as attractants or nutrients. The combination of the active agent(s) and the inactive ingredients achieves synergistic effect in pest control.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: January 17, 2023
    Inventors: Chunbo Zhang, Ligang Qian, Hongyue Zhang
  • Publication number: 20200236932
    Abstract: Disclosed are compositions and methods of pest control. The composition contains one or more active agents such as a polyalcohol, carbohydrate, nucleobase or nucleotide compound or derivative and one or more inactive ingredients which function as attractants or nutrients. The combination of the active agent(s) and the inactive ingredients achieves synergistic effect in pest control.
    Type: Application
    Filed: September 21, 2016
    Publication date: July 30, 2020
    Inventors: Chunbo Zhang, Ligang Qian, Hongyue Zhang
  • Publication number: 20170085076
    Abstract: A setting and coordination calculation method for protection setting value of DC system is introduced. A protective template library is built by classifying the DC system protections to various protective areas and classifying each protective area. Based on project configuration, a mathematical model of converter station is built, the parameters of equipment components and locations of short circuit are given. The short-circuit current value and the parameters of equipment component are regarded as process parameters during the setting and coordination. The electromagnetic transient simulation is carried out at first in this method. And a specified and standard project of the setting and coordination is formed by abstracting and standardizing the process of the setting and coordination, which makes present setting and coordination of DC transmission engineering independent of the electromagnetic transient simulation software.
    Type: Application
    Filed: March 21, 2016
    Publication date: March 23, 2017
    Inventors: Hongyue Zhang, Zhenhua Zhang, Hailong Chen, Ganjie Chen, Kun Zhang, Yujie Xu, Yanhui Du, Zhenyu Lu, Zhilei Niu, Youbin An, Yanru Zhao, Shaohui Huang
  • Patent number: 6825226
    Abstract: The invention relates to the discovery that specific adamantyl or adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for the treatment of cancer, including advanced cancer. Also, the present invention relates to novel adamantyl or adamantyl group derivatives containing retinoid compounds and their usage for treatment and/or prevention of cancer, keratinization disorders, dermatological conditions, and other therapies More specifically, it has been shown that such adamantyl compounds, e.g., 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoicacid, 2-[3-(1-adamantyl)-4-methoxyphenyl]-5-benzimidazole carboxylic acid, and 6-[3-(1-adamantyl)-4,5-methylenedioxyphenyl]-2-naphthoic acid, can be used to treat or prevent cervical cancers and precancers such as cervical dysplasias, including high grade and low grade dysplasias.
    Type: Grant
    Filed: June 24, 2002
    Date of Patent: November 30, 2004
    Assignee: Galderma Research & Development, S.N.C.
    Inventors: Magnus Pfahl, Xian-Ping Lu, Darryl Rideout, Hongyue Zhang
  • Publication number: 20030073745
    Abstract: The invention relates to the discovery that specific adamantyl or adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for the treatment of cancer, including advanced cancer. Also, the present invention relates to novel adamantyl or adamantyl group derivatives containing retinoid compounds and their usage for treatment and/or prevention of cancer, keratinization disorders, dermatological conditions, and other therapies More specifically, it has been shown that such adamantyl compounds, e.g., 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoicacid, 2-[3-(1-adamantyl)-4-methoxyphenyl]-5-benzimidazole carboxylic acid, and 6-[3-(1-adamantyl)-4,5-methylenedioxyphenyl]-2-naphthoic acid, can be used to treat or prevent cervical cancers and precancers such as cervical dysplasias, including high grade and low grade dysplasias.
    Type: Application
    Filed: June 24, 2002
    Publication date: April 17, 2003
    Inventors: Magnus Pfahl, Xian-Ping Lu, Darryl Rideout, Hongyue Zhang
  • Patent number: 6462064
    Abstract: The invention relates to the discovery that specific adamantyl or adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for the treatment of cancer, including advanced cancer. Also, the present invention relates to novel adamantyl or adamantyl group derivatives containing retinoid compounds and their usage for treatment and/or prevention of cancer, keratinization disorders, dermatological conditions, and other therapies More specifically, it has been shown that such adamantyl compounds, e.g., 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid, 2-[3-(1-adamantyl)-4-methoxyphenyl]-5-benzimidazole carboxylic acid, and 6-[3-(1-adamantyl)-4,5-methylenedioxyphenyl]-2-naphthoic acid, can be used to treat or prevent cervical cancers and precancers such as cervical dysplasias, including high grade and low grade dysplasias.
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: October 8, 2002
    Assignee: Galderma Research & Development S.N.C.
    Inventors: Magnus Pfahl, Xian-Ping Lu, Darryl Rideout, Hongyue Zhang
  • Patent number: 6127415
    Abstract: The present invention relates to specific adamantyl or adamantyl group derivative containing retinoid compounds induce apoptosis of cancer cells. These adamantyl retinoid derivatives are useful for the treatment of many cancers and solid tumors, especially androgen-independent prostate cancer, skin cancer, pancreatic carcinomas, colon cancer, melanoma, ovarian cancer, liver cancer, small cell lung carcinoma, non-small cell lung carcinoma, cervical carcinoma, brain cancer, bladder cancer, breast cancer, neuroblastoma/glioblastoma, and leukemia. Also, the invention relates to novel adamantyl or adamantyl group derivative compounds which are useful as active agents for the treatment or prevention of keratinization disorders and other dermatological conditions, and other diseases.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: October 3, 2000
    Assignee: Galderma Research & Development, S.N.C.
    Inventors: Magnus Pfahl, Xian-Ping Lu, Darryl Rideout, Hongyue Zhang